Siemens Healthineers nwetara ikike iji ihe mberede FDA maka nnwale mgbochi SARS-CoV-2

New York-izu gara aga, nchịkwa nri na ọgwụ nyere Siemens Healthineers ikike iji ihe mberede mee ihe maka ule Advia Centaur SARS-CoV-2 IgG ma ọ bụ sCOVG.
Emebere immunoassay Chemiluminescence maka nyocha nke ogo na ọkara nke immunoglobulin G ma ọ bụ IgG megide SARS-CoV-2 na serum na plasma.A na-eme ule a na Siemens' Advia Centaur XP, Advia Centaur XPT na Advia Centaur CP immunoassay sistemu.
Dị ka FDA si kwuo, ụlọ nyocha ọ bụla nke CLIA nwere ike iji ule a mee ule na-agafeghị oke ma ọ bụ dị mgbagwoju anya.
Na Machị nke afọ a, SARS-CoV-2 IgG immunoassay nke Siemens AG na-arụ, nke dị na Erlangen, Germany, na nyocha Atellica IM, natara EUA sitere na FDA.
Amụma nzuzo.Usoro na ọnọdụ.Nwebiisinka © 2021 GenomeWeb, ngalaba azụmahịa nke Crain Communications.ikike niile echekwabara.